The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma

By Cheson Bruce D.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 309-322

Adis International

Access to resources Recommend Favorite

Radioimmunotherapy for Indolent B-Cell Non-Hodgkin Lymphoma in Relapsed, Refractory and Transformed Disease

By Visser Otto J.  

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 201-207

Adis International

Access to resources Recommend Favorite

Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma: Targeting the Idiotypic Immunoglobulin

By Armstrong Anne C.   Cheadle Eleanor J.   Hawkins Robert E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite

Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

By Cvetković Risto S.   Perry Caroline M.  

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 253-257

Adis International

Access to resources Recommend Favorite

Autologous transplantation for diffuse aggressive Non-Hodgkin lymphoma in first relapse or second remission

By Vose J.M.   Rizzo D.J.   Tao-Wu J.   Armitage J.O.   Bashey A.   Burns L.J.   Christiansen N.P.   Freytes C.O.   Gale R.P.   Gibson J.   Giralt S.A.   Herzig R.H.   Lemaistre C.F.   McCarthy P.L.   Nimer S.D.   Petersen F.B.   Schenkein D.P.   Wiernik P.H.   Wiley J.M.   Loberiza F.R.   Lazarus H.M.   van Biesen K.   Horowitz M.M.  

Biology of Blood and Marrow Transplantation, Vol. 10, Iss. 2, 2004-02 ,pp. : 116-127

Elsevier

Access to resources Recommend Favorite